Immunization, Hib3 in Republic of Moldova
Republic of Moldova: Immunization, Hib3 was 87.0% in 2024. ▲ Rising
Immunization, Hib3 in Republic of Moldova, 2009–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
In 2024, immunization, hib3 in Republic of Moldova stood at 87.0%.
The figure is down 2.2% over ten years.
Over the whole period, immunization, hib3 in Republic of Moldova peaked at 93.0% in 2018 and was at its lowest, 47.0%, in 2009.
That places Republic of Moldova 117th out of 191 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 16 years of available data.
Immunization, Hib3 in Republic of Moldova, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2009 | 47.0% | — |
| 2010 | 63.0% | +34.0% |
| 2011 | 78.0% | +23.8% |
| 2012 | 90.0% | +15.4% |
| 2013 | 89.0% | -1.1% |
| 2014 | 89.0% | +0.0% |
| 2015 | 87.0% | -2.2% |
| 2016 | 89.0% | +2.3% |
| 2017 | 88.0% | -1.1% |
| 2018 | 93.0% | +5.7% |
| 2019 | 90.0% | -3.2% |
| 2020 | 86.0% | -4.4% |
| 2021 | 87.0% | +1.2% |
| 2022 | 87.0% | +0.0% |
| 2023 | 87.0% | +0.0% |
| 2024 | 87.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 47.0% | 47.0% | 47.0% | 1 |
| 2010s | 85.6% | 63.0% | 93.0% | 10 |
| 2020s | 86.8% | 86.0% | 87.0% | 5 |
Countries ranked near Republic of Moldova
- 114 Belize 88.0% compare
- 114 Germany 88.0% compare
- 114 Palestine, State of 88.0% compare
- 117 Pakistan 87.0% compare
- 117 San Marino 87.0% compare
- 117 Sao Tome and Principe 87.0% compare
- 117 Solomon Islands 87.0% compare
More health data for Republic of Moldova
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2486 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,492 deaths per 1,000 people (2090)
- Number of infants who die before age 1 29 deaths (2100)
- Population ages 15-19, male, annual growth rate 1.77 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0312 units per person (2025)
- Population ages 20-24, female, annual growth rate 0.637 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0256 units per person (2025)
Frequently asked questions
- What is immunization, hib3 in Republic of Moldova?
- Immunization, hib3 in Republic of Moldova was 87.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Republic of Moldova?
- The highest recorded value was 93.0% in 2018.
- What is the lowest immunization, hib3 recorded in Republic of Moldova?
- The lowest recorded value was 47.0% in 2009.
- How does Republic of Moldova rank for immunization, hib3?
- Republic of Moldova ranks 117th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Republic of Moldova?
- Over the last ten years it is down 2.2%. The long-run trend across the full record is rising.
- Where does this Republic of Moldova data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.